{"id":"W3097923020","doi":"10.1182/blood-2020-135839","title":"Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Clinical trial; Oncology; Progressive disease; Lymphoma; Phases of clinical research; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002922712,0.000616328,0.001321568,0.0002460796,0.000266095,0.001005175,0.000508135,0.0005206185,0.001071671],"category_scores_gemma":[0.001575882,0.0002452951,0.0008085183,0.0004616226,0.0003695368,0.0006491062,0.0002996643,0.001815372,0.0003214311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006493612,"about_ca_system_score_gemma":0.0006045973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005799248,"about_ca_topic_score_gemma":0.00155075,"domain_scores_codex":[0.9993834,0.0002583567,0.00005897604,0.00008002549,0.0001226328,0.00009654242],"domain_scores_gemma":[0.999146,0.00023281,0.0002151923,0.00008676756,0.0001092844,0.0002098919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1211032,0.01402598,0.04367993,0.001795012,0.00545971,0.0009469049,0.001250258,0.00459218,0.08790459,0.0005655739,0.01956804,0.6991086],"study_design_scores_gemma":[0.2231459,0.3316745,0.3166126,0.0007867746,0.006986446,0.005972981,0.0005192094,0.006781058,0.02227533,0.001426149,0.08358982,0.0002292873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9696268,0.02136686,0.001199351,0.001226264,0.00009028446,0.0009123444,0.00142736,0.0001169938,0.00403368],"genre_scores_gemma":[0.981475,0.00933637,0.001900101,0.001571497,0.0001600843,0.0006854148,0.003784829,0.00004228426,0.001044411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002922712,"threshold_uncertainty_score":0.01545697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03321688991683865,"score_gpt":0.3106191460288156,"score_spread":0.2774022561119769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}